Literature DB >> 2320070

Second thoughts about second-look laparotomy in advanced ovarian cancer.

J B Friedman1, N S Weiss.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2320070     DOI： 10.1056/NEJM199004123221512

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Surgical staging of cancer: impact on prognosis and potential for bias in clinical trials.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

2.  Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.

Authors:  Munetaka Takekuma; Makoto Maeda; Takachika Ozawa; Kazuhiko Yasumi; Tatsuo Torizuka
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

Review 3.  Current drug treatment guidelines for epithelial ovarian cancer.

Authors:  P C Lorigan; T Crosby; R E Coleman
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Second-look laparotomies in ovarian cancer: a medical oncologist's perspective.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study.

Authors:  Hee Seung Kim; Tae Joong Kim; Hyun Hoon Chung; Jae Weon Kim; Byung Gie Kim; Noh Hyun Park; Yong Sang Song; Duk Soo Bae; Soon Beom Kang
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-16       Impact factor: 4.553

Review 6.  Ovarian cancer: the clinical role of US, CT, and MRI.

Authors:  Kaori Togashi
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

7.  Staging recurrent ovarian cancer with (18)FDG PET/CT.

Authors:  Sanja Dragosavac; Sophie Derchain; Nelson M G Caserta; Gustavo DE Souza
Journal:  Oncol Lett       Date:  2012-12-13       Impact factor: 2.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.